Industry NewsLife Sciences SeraNovo enters license agreement with Carna Biosciences to develop an oral formulation of Carna’s kinase inhibitor
Industry NewsClinical Diagnostics FDA approves first targeted therapy to treat aggressive form of lung cancer
Application NoteAnalysis of tyrosine kinase signaling in human cancer by stable isotope labeling with heavy amino acids in mouse xenografts utilizing Mouse Express Lysine 13C6 Mouse Feed
Scientific PosterAnalysis of the Effect of Aggregated β-Amyloid on Cellular Signaling Pathways Critical for Memory in Alzheimer’s Disease
Industry NewsSeraNovo enters license agreement with Carna Biosciences to develop an oral formulation of Carna’s kinase inhibitor
